The insulin receptor substrate-1 (IRS-1) is a docking protein of the insulin-like growth factor-1 (IGF-1) receptor and of the insulin receptor. IRS-1 sends a strong mitogenic, anti-apoptotic signal and plays an important role in cell transformation and cancer. IRS-1 translocates to nuclei of cells, where it increases the activity of the rDNA, c-myc and cyclin D1 promoters. We show, by chromatin immunoprecipitation, occupancy by IRS-1 of the same promoters. Both promoter activation and promoter occupancy are IGF-1-dependent. In cells that respond to IGF-1 but in which IRS-1 does not translocate to nuclei, promoter occupancy is absent and promoter activation is absent or much reduced. Transcriptional activation of c-myc and cyclin D1 promoters by nuclear IRS-1 does not occur with a mutant, inactive IRS-1 protein (deletion of the phosphotyrosine-binding domain, PTB) and does not require PI3-kinase activity. Taken together, these results indicate a novel mechanism by which nuclear IRS-1 activates cell cycle genes.
Introduction
The insulin receptor substrate-1 (IRS-1) is a docking protein for both the insulin receptor (InR) and the type 1 insulin-like growth factor receptor (IGF-IR). It binds to and activates PI3-K and plays an important role in signal transduction from these receptors (White, 1998) . IRS-1 has many functions, but it has three major, well-characterized biological functions: it regulates cell and body size; it inhibits differentiation; and it promotes transformation of cells. This last property of IRS-1 is the focus of the present communication. When IRS-1 levels are decreased by experimental procedures, cancer cells lose their transformed phenotype (D'Ambrosio et al., 1995; del Rincon et al., 2004) . Over-expression or ectopic expression of IRS-1 causes cell transformation, including the ability to form colonies in soft agar and tumors in mice (Cristofanelli et al., 2000; Valentinis et al., 2000; DeAngelis et al., 2006; Dearth et al., 2006) . IRS-1 is often over-expressed in human cancer (Chang et al., 2002) .
IRS-1 signaling is traditionally explained by its ability to activate the PI3-K signaling pathway. More recently, IRS-1 has been found in nuclei and nucleoli of cells, either after stimulation with IGF-1 (Tu et al., 2002) , or in association with the T antigens of SV40 or its human equivalent (Lassak et al., 2002; Prisco et al., 2002) . Nuclear IRS-1 binds the upstream binding factor 1 (UBF1), one of the proteins that regulate RNA polymerase I activity (Tu et al., 2002) .
In a previous report, we showed IRS-1 occupancy of the rDNA promoter and activation of the Tcf/Lef promoter in mouse embryonic fibroblasts (MEFs) (Chen et al., 2005) . We have asked now whether a nuclear IRS-1 could alter expression of genes involved in cell cycle progression, especially RNA polymerase-II-directed promoters.
For this purpose, we investigated the effect of nuclear IRS-1 on the activities of the c-myc, cyclin D1 and rDNA promoters. Using chromatin immunoprecipitation (ChIPs) and reporter genes, we show that nuclear IRS-1 localizes in and activates the c-myc, cyclin D1 and rDNA promoters. In absence of nuclear translocation, IRS-1 is not detectable in these promoters, and their activation is dramatically reduced. In addition, we show that a defective IRS-1 (deletion of the phosphotyrosinebinding domain, PTB) fails to activate the c-myc and cyclin D1 promoters. Activation of cyclin D1 and c-myc promoters by nuclear IRS-1 does not require PI3-K activity. Taken together, these results indicate a novel role of nuclear IRS-1 in activation of at least four cell cycle progression genes. The mechanism is also novel since it is IGF-1-but not PI3-K-dependent.
Results
In transformed MEFs with high IGF-IR numbers, like R þ cells (Sell et al., 1993) , IRS-1 is largely nuclear (Tu et al., 2002) . In cells with lower numbers of IGF-IR (R12 cells, and other cell types), IRS-1 is confined to the cytoplasm. We have taken advantage of these differences to investigate the mechanism(s) by which nuclear IRS-1 affects the activity of cell cycle progression genes. We have compared three cell lines: R þ cells (wild-type IRS-1), R12/NLS/IRS1 cells and R12 MEFs (cytoplasmic IRS-1). In the R12/NLS/IRS1 cell line, R12 cells express an IRS-1 with a nuclear localization signal (NLS). Since R12/NLS/IRS1 cells are essentially R12 cells with a nuclear IRS-1, the comparison between these two cell lines focuses the differences on the subcellular localization of IRS-1. The use of R þ cells, in which IRS-1 is physiologically nuclear, eliminates the objection of artifacts in NLS/IRS1 cells. We have studied in these cells the four promoters that play an important role in cell cycle progression: c-myc, cyclin D1, Tcf (b-catenin-dependent) and rDNA promoters.
Activation of the cyclin D1 and c-myc promoters in R þ and RÀ cells stimulated by IGF-1 In R þ cells stimulated with IGF-1, IRS-1 is nuclear, and rDNA promoter activity and rRNA synthesis increase sharply (Tu et al., 2002; Wu et al., 2005) . By ChIPs, IRS-1 is detectable in the rDNA promoter (Chen et al., 2005) . IGF-1 fails to translocate IRS-1 to nuclei of RÀ cells (Tu et al., 2002) that are MEFs with a targeted disruption of the IGF-IR genes (Sell et al., 1993) . We asked whether nuclear IRS-1 in R þ cells would also increase transcription from RNA polymerase II promoters. We transiently transfected into R þ cells the two reporter genes, one with the cyclin D1 promoter (Rowlands et al., 2003) and the other with the c-myc promoter (He et al., 1998) , both driving luciferase. Figure 1a , shows that IGF-1 stimulation of R þ cells increases the activities of both c-myc and cyclin D1 promoters. As control, we used the parental cell line, RÀ cells (Sell et al., 1993) that do not express IGF-IRs. Stimulation of RÀ cells by IGF-1 did not increase activity of the promoters.
Activation of the c-myc, cyclin D1 and Tcf/Lef promoters in R12/NLS/IRS1 cells From R12 cells, in which IRS-1 remains cytoplasmic after IGF-1 stimulation, we generated a new cell line, in which nuclear translocation of IRS-1 was achieved by stable transfection of a plasmid expressing a wild-type IRS-1 with an NLS. Figure 2 shows that the c-myc, cyclin D1 and Tcf/Lef promoters are sharply activated in R12/NLS/IRS1 cells stimulated with IGF-1. The activity of the Tcf/LEF promoter, using the TOP-FLASH/FLOPFLASH luciferase assay, is also markedly increased (Figure 2c ), confirming the results of Chen et al. (2005) , who also showed that R12/NLS/ IRS1 cells are transformed (colony formation in soft agar).
Occupancy of the rDNA, cyclin D1 and c-myc promoters in R12/NLS/IRS1 cells Fragmented chromatin was immunoprecipitated with antibodies to UBF, IRS-1, c-myc and Stat3, and the immunoprecipitates were examined by PCR for occupancy of the rDNA and cyclin D1 promoters (Figure 3 ). Stat3 antibody was used because Stat3 activates the cyclin D1 promoter. In R12/NLS/IRS1 cells, IRS-1, c-myc and Stat3 are detectable in rDNA and cyclin D1 promoters, after stimulation with IGF-1. The presence of Stat3 in the rDNA promoter was unexpected. However, IGF-1R signaling is known to activate Stat3 (Peterson et al., 1994) .
The c-myc promoter is extensive, and we followed a previous paper (He et al., 1998) in examining it in sections, using appropriate PCR primers. All sections, by ChIPs, were negative, except the section from þ 48 to þ 236 (Figure 3c ). In this section of the c-myc promoter, UBF was present even in serum-free medium (SFM), while IRS-1 and c-myc appeared after stimulation. Stat3 was not detectable in any segment of the c-myc promoter (À1054 þ 236) we investigated ( Figure 3 ).
Activation and occupancy of the promoters in R12 cells
We tested in R12 cells (cytoplasmic IRS-1) the same promoters, and the results are shown in Figure 4a . Increases in activity of the three promoters over 0 time are minimal. We monitored promoter occupancy in these cells, and the results are shown in Figure 4b . The only protein detected in the rDNA, cyclin D1 and c-myc promoters of R12 cells is the Nuclear IRS-1 and transcription A Wu et al UBF protein, an exquisitely nuclear/nucleolar protein (Tu et al., 2002) .
Effects of mutant nuclear IRS-1 proteins on the activity of cyclin D1 and c-myc promoters We tested two mutant IRS-1, described previously (Reiss et al., 2001) . One mutant has a deletion of the PTB domain, is inactive and does not translocate to nuclei . The other mutant has mutations at the PI3-K binding sites, mutated to phenylalanines, and has decreased activity. Both mutants were inserted into the NLS plasmid and co-transfected with reporter genes into R12 cells. Figure 5a shows that the nuclear PTB mutant fails to activate c-myc and cyclin D1 promoters. The PI3-K binding sites mutant is as effective as wild-type IRS-1 in activating both promoters. The nuclear localization of mutant IRS-1 in transiently transfected R12 cells is shown in Figure 5b . Both mutants localize to nuclei. Untransfected cells in the picture (red nuclei in the merged picture) serve as controls for the IRS-1 antibody that detects IRS-1 in the cytosol only of untransfected cells.
Activation of rDNA promoter Nuclear IRS-1 increases the activity of the rDNA promoter and rRNA synthesis in myeloid cells and MEFs Tu et al., 2002) . The activity of the rDNA promoter, using a reporter gene increases in R12/NLS/IRS1 cells after IGF-1 stimulation. (Figure 6a ). There is also a modest increase in R12 cells at 24 h that represent the activation of the rDNA promoter through the conventional signal transduction pathway. Total RNA accumulation also increases in R12/NLS/IRS1 cells after IGF-1 stimulation ( Figure 6b ).
Status of nuclear IRS-1 phosphorylation in R12 cells
A puzzling observation with ChIPs and reporter genes was that promoter occupancy and activation still required IGF-1 stimulation even in R12/NLS/IRS1 cells, where IRS-1 is largely nuclear in SFM. IRS-1 is translocated to the nuclei in cells that express the SV40T antigen or its human equivalent (Lassak et al., 2002) . However, T antigen cannot transform MEFs unless IRS-1 is tyrosyl phosphorylated (DeAngelis et al., 2006) . We, therefore, tested the phosphorylation status of IRS-1 using an antibody to IRS-1 phosphorylated on tyrosine 608 on nuclear lysates of parental R12, R12/IRS1/NLS and R þ cells Figure 7a shows that LY294002 and wortmannin do not inhibit the activity of the c-myc promoter in R þ or R12/NLS/IRS1 cells. LY294002 has little effect on the activity of the rDNA promoter (Figure 7b ), although a modest decrease in R12/NLS/ IRS1 cells was reproducible. Figure 7c shows that exposure of cells to LY294002 does inhibit the phosphorylation of Akt, even at 8 h after addition. Wortmannin was also effective in inhibiting Akt phosphorylation (not shown).
Discussion
Novel findings in this communication are (1) markedly increase activation and occupancy of the cyclin D1 and c-myc promoters in cells with a nuclear IRS-1; (2) activation of the c-myc and cyclin D1 promoters requires an active IRS-1. Deletion of its PTB domain abrogates promoters' activation; (3) promoter activation is PI3-K-independent, although it is IGF-1-dependent; (4) nuclear IRS-1 is found in the rDNA promoter and (5) nuclear IRS-1 activates the rDNA and Tcf/Lef promoters more strongly than when IRS-1 is cytoplasmic. We propose that nuclear IRS-1 increases the activation of certain cell cycle progression genes, also activated, but to a lesser extent, by cytoplasmic IRS-1. Our results show that occupancy of the rDNA, cyclin D1 and c-myc promoters occurs only when IRS-1 is nuclear (this paper). There is activation of the rDNA promoter when IRS-1 is cytoplasmic, but it increases markedly when IRS-1 is nuclear and this paper). Nuclear IRS-1 has the same effects of cytoplasmic IRS-1, but magnified. This is a novel function of IRS-1, seemingly separate from its traditional signal transduction pathway. 
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The c-myc and cyclin D1 promoters are activated by a wild-type nuclear IRS-1 protein, but not by an inactive nuclear IRS-1 protein with a deletion of the PTB domain. The activation of cyclin D1 and c-myc promoters by nuclear IRS-1 does not require signaling from PI3-K, which was unexpected. It occurs with a nuclear IRS-1 with mutated PI3-K binding sites and when wild-type IRS-1 signaling is inhibited by PI3-K inhibitors. The situation is more complex with the rDNA promoter. The inhibitor LY294002 only slightly decreases the activity of the rDNA promoter. The persistent but decreased activity of the rDNA promoter in the presence of LY294002 suggests that IRS-1 may activate the rDNA promoter by direct interaction with other rDNA promoter proteins but also through a nuclear PI3-K. There is, therefore, a difference in PI3-K independence between the rDNA promoter (RNA polymerase I) and the c-myc, cyclin D1 and Tcf/Lef promoters (RNA polymerase II).
In R þ cells, IGF-1 stimulation causes nuclear translocation of IRS-1 while in R12/NLS/IRS1 cells, nuclear localization was enforced by transfection with a plasmid in which IRS-1 was expressed with an NLS (Chen et al., 2005) . Parental R12 cells, where IRS-1 remains cytoplasmic, were the negative control. R12/ NLS/IRS1 cells clearly show that the presence of IRS-1 in the nuclei is sufficient to activate promoters under conditions in which they are not activated by a cytosolic IRS-1. The same results are obtained in R þ cells, where IRS-1 translocates to the nuclei when the cells are stimulated by IGF-1 (this paper).
UBF was always present in all promoters and all cell lines, while IRS-1 occupancy of the promoters still required IGF-1 stimulation. This observation raises the important question: with a nuclear IRS-1, why is IGF-1 stimulation still necessary for promoter occupancy? Since the other proteins (c-myc and Stat3) also require stimulation, one can hypothesize that promoter occupancy (and the subsequent promoter activation) requires the co-participation of other signaling-pathway proteins that are activated by other growth factors. The specificity of IGF-1 stimulation in R þ and R12/IRS1/ NLS cells is confirmed by the fact that IGF-1 fails to The requirement for IGF-1 stimulation even in cells expressing an IRS-1 with an NLS is puzzling, but a possible explanation is that IRS-1 has to bind to other proteins to exert an action, and that this requires its activation. Our data show that the PTB mutant is inactive even when forcibly translocated to nuclei (Figure 8) .
One can only speculate at this point whether the increased transcription caused by nuclear IRS-1 is responsible for the transformed phenotype. IRS-1 increases transcription from the rDNA, cyclin D1 and c-myc promoters. The role of IRS-1 in transcription is in all likelihood indirect, through its interaction with other promoters' proteins. IRS-1 has no DNA-binding motifs, and it is not a kinase (from the database). Angelov et al. (2006) have reported that nucleolin is a histone chaperone that facilitates transcription through the nucleosome. IRS-1, which interacts with many proteins , may work in the same way as nucleolin in facilitating transcription.
In conclusion, we have shown that a nuclear IRS-1 regulates the activity of the rDNA, cyclin D1 and c-myc promoters. With the possible exception of the rDNA promoter, the regulation requires an active IRS-1 but does not require the ability to activate PI3-K, an obligatory step in the traditional signal transduction pathway. It is reasonable to hypothesize that nuclear IRS-1 will be found to exert a profound influence on cellular processes related to cell size and cell cycle progression.
Materials and methods
Cells and cell cultures RÀ cells and RÀ derived cells are 3T3-like cells originating from mouse embryos with a targeted disruption of the IGF-IR genes. They have been described in previous papers (Sell et al., 1993; Reiss et al., 2001) and in the Results section.
Plasmids
The plasmid with an NLS was the pCMV/myc/nuc plasmid from Invitrogen (Carlsbad, CA, USA). IRS-1 was cloned in the XhoI/NotI site. Expression and localization of IRS-1/NLS in MEFs has been documented previously (Chen et al., 2005) . The same procedure was used to clone in the NLS plasmid the two IRS-1 mutants, the first with a PTB deletion and the other with a mutation of the PI3-K binding sites (Reiss et al., 2001) .
Reporter plasmids
The c-Myc promoter driving luciferase (He et al., 1998) was a kind gift from Dr Bert Vogelstein (Johns Hopkins University). The cyclin D1 promoter, also driving luciferase (Rowlands et al., 2003) , was a gift from Dr Richard Pestell (Thomas Jefferson University). Luciferase determination was carried out by standard procedures. For the activation of the rDNA promoter, we used the reporter previously described by Wu et al. (2005) .
ChIP assays
ChIP assays were carried out by standard methods (Chen et al., 2005) .
Taqman real-time RT-PCR Total RNA was extracted using RNeasy Min kit (Qiagen, Valencia, CA, USA, Cat#74104). TaqMan One-step RT-PCR Master Mix Reagents Kit (ABI, Roche, Branchbrug, NJ, USA; Cat# 4309169) was used to determine RNA amounts (85% of the total RNA is ribosomal RNA). We followed the methodology recommended by the manufacturer.
Antibodies
The following antibodies were used: IRS-1 rabbit polyclonal IgG; UBF, mouse monoclonal IgG1; c-Jun, rabbit polyclonal IgG; SV40 Tag mouse monoclonal IgG2a; Stat3 rabbit polyclonal IgG; c-Myc mouse monoclonal IgG were all from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-IRS-1 (pTyr608) rabbit pAb was from Calbiochem (San Diego, CA, USA) and anti-Grb2 monoclonal antibody from BD Transduction Laboratory. Second antibodies: antirabbit Ig, horseradish peroxidase linkF(ab 0 )2fragment (from donkey) Nuclear IRS-1 and transcription A Wu et al
